<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67286">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02112539</url>
  </required_header>
  <id_info>
    <org_study_id>Val 0072-B</org_study_id>
    <nct_id>NCT02112539</nct_id>
  </id_info>
  <brief_title>Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Effect of ADP Blocking Drugs on Platelet Aggregation on the AggreGuide A-100 Instrument</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aggredyne, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aggredyne, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to characterize the AggreGuide ADP Assay's performance.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Platelet Activity Index (PAI)</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>PAI at baseline and after taking ADP blocking antiplatelet drugs.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Platelet Aggregation</condition>
  <condition>ADP Blockers</condition>
  <arm_group>
    <arm_group_label>ADP Blockers</arm_group_label>
    <description>platelet aggregation in response to antiplatelet drugs</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>platelet aggregation measurement</intervention_name>
    <arm_group_label>ADP Blockers</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-75

        Exclusion Criteria:

          -  less than 60 kg

          -  on antiplatelet meds other than aspirin

          -  antiplatelet drugs contraindicated
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward Teitel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unafilliated</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miguel Posada</last_name>
    <phone>713-779-5494</phone>
    <email>miguel_posada@junoresearch.us</email>
  </overall_contact>
  <location>
    <facility>
      <name>Juno Research</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Audry Lacour, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 10, 2014</lastchanged_date>
  <firstreceived_date>April 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
